Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/108186
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Makowski, Kamil |
dc.contributor.author | Vigevani, Luisa |
dc.contributor.author | Albericio Palomera, Fernando |
dc.contributor.author | Valcárcel, Juan |
dc.contributor.author | Álvarez Domingo, Mercedes |
dc.date | 2017-03-09T15:07:47Z |
dc.date | 2017-11-24T23:01:22Z |
dc.date | 2016-11-24 |
dc.date | 2017-03-09T15:07:47Z |
dc.identifier.citation | 1554-8929 |
dc.identifier.uri | http://hdl.handle.net/2445/108186 |
dc.format | 11 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | American Chemical Society |
dc.relation | Versió postprint del document publicat a: https://doi.org/10.1021/acschembio.6b00562 |
dc.relation | ACS Chemical Biology, 2016, vol. 12, num. 1, p. 163-173 |
dc.relation | https://doi.org/10.1021/acschembio.6b00562 |
dc.rights | (c) American Chemical Society, 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Càncer |
dc.subject | Medicaments |
dc.subject | Inhibidors enzimàtics |
dc.subject | Cancer |
dc.subject | Drugs |
dc.subject | Enzyme inhibitors |
dc.title | Sudemycin K: a synthetic anti-tumor splicing inhibitor variant with improved activity and versatile chemistry |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |